BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1641982)

  • 1. The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.
    Göttlinger HG; Dorfman T; Cohen EA; Haseltine WA
    Virology; 1992 Aug; 189(2):618-28. PubMed ID: 1641982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
    Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
    J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    Benko DM; Schwartz S; Pavlakis GN; Felber BK
    J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tripartite HIV-1 tat-env-rev fusion protein.
    Salfeld J; Göttlinger HG; Sia RA; Park RE; Sodroski JG; Haseltine WA
    EMBO J; 1990 Mar; 9(3):965-70. PubMed ID: 2178928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
    Riggs NL; Little SJ; Richman DD; Guatelli JC
    Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA.
    Unger RE; Stout MW; Luciw PA
    Virology; 1991 May; 182(1):177-85. PubMed ID: 2024463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR
    Infect Agents Dis; 1994; 3(2-3):68-76. PubMed ID: 7812657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
    Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
    Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
    Furtado MR; Balachandran R; Gupta P; Wolinsky SM
    Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Staffa A; Cochrane A
    Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico mutagenesis of RNA splicing in HIV-1.
    Kim H; Yin J
    Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling elements in replication of the human immunodeficiency virus type 1.
    Li X; Quan Y; Wainberg MA
    Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):443-54. PubMed ID: 9193800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of Tat and Rev transactivators in the primate lentiviruses.
    Sakai H; Sakuragi J; Sakuragi S; Kawamura M; Adachi A
    Arch Virol; 1993; 129(1-4):1-10. PubMed ID: 8385908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
    Kammler S; Leurs C; Freund M; Krummheuer J; Seidel K; Tange TO; Lund MK; Kjems J; Scheid A; Schaal H
    RNA; 2001 Mar; 7(3):421-34. PubMed ID: 11333022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
    Stephens RM; Derse D; Rice NR
    J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.